Assessment of killer cell immunoglobulinlike receptor expression and corresponding HLA class I phenotypes demonstrates heterogenous KIR expression independent of anticipated HLA class I ligands

Human Immunology

Volumn 64, Issue 2, 2003, Pages 183-193

  Becker, Sven ^a   Tonn, Torsten ^a   Füssel, Tobias ^a   Uhrberg, Markus ^b   Bogdanow, Manuela ^c   Seifried, Erhard ^a   Seidl, Christian ^a,d  

^a RCBDS   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c UNIVERSITY OF BONN   (Germany)

^d Inst Transfusionsmed/Immunhamatol   (Germany)

Author keywords

HLA; KIR; Natural killer cell receptor

Indexed keywords

EPITOPE; HLA ANTIGEN CLASS 1; HLA C ANTIGEN; IMMUNOGLOBULIN RECEPTOR; LIGAND;

ANTIGEN EXPRESSION; ARTICLE; CELL INTERACTION; CONTROLLED STUDY; CYTOLYSIS; DOWN REGULATION; FLOW CYTOMETRY; GENE EXPRESSION; GENOTYPE; HUMAN; HUMAN CELL; NATURAL KILLER CELL; PHENOTYPE; PRIORITY JOURNAL; TARGET CELL;

EID: 0037316373     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(02)00802-9     Document Type: Article

References (46)

1. Lanier LL: Follow the leader: NK cell receptors for classical and nonclassical MHC class I. Cell 92:705, 1996.
2. Moretta L, Bottino C, Pende D, Mingari MC, Biassoni R, Moretta A: Human natural killer cells: their origin, receptors and function. Eur J Immunol 32:1205, 2002.
3. Borges L, Hsu ML, Fanger N, Kubin M, Cosman D: A family of human lymphoid and myeloid Ig-like receptors, some of which bind to MHC class I molecules. J Immunol 159:5192, 1997.
4. Samaridis J, Colonna M: Cloning of novel immunoglobulin superfamily receptors expressed on human myeloid and lymphoid cells: structural evidence for new stimulatory and inhibitory pathways. Eur J Immunol 27:660, 1997.
5. Wende H, Volz A, Ziegler A: Extensive gene dublications and large inversion characterize the human leukocyte receptor cluster. Immunogener 51:703, 2000.
6. Falk CS, Steinle A, Schendel DJ: Expression of HLA-C molecules confers target cell resistance to some non-major histocompatibility complex-restricted T cells in a manner analogous to allospecific natural killer cells. J Exp Med 182:1005, 1995.
7. Mingari MC, Schiavetti F, Ponte M, Vitale C, Maggi E, Romagnani S, Demarest J, Pantaleo G, Fauci AS, Moretta L: Human CD8+ T lymphocyte subsets that express HLA class I specific inhibitory receptors represent oligoclonally or monoclonally expanded cell populations. Proc Natl Acad Sci USA 93:12433, 1996.
8. Phillips JH, Gumperz JE Parham P, Lanier LL: Superantigen-dependent, cell-mediated cytotoxicity inhibited by MHC class I receptors on T lymphocytes. Science 268:403, 1995.
9. Young NT, Uhrberg M, Phillips JH, Lanier LL, Parham P: Differential expression of leukocyte receptor complex-encoded Ig-like receptors correlates with the transition from effector to memory CTL. J Immunol 166:3922, 2001.
10. Uhrberg M, Valiante NM, Young NT, Lanier LL, Phillips JH, Parham P: The repertoire of KIR and CD94: NKG2A receptors in T cells: clones sharing identical αβ TCR rearrangement express highly diverse KIR patterns. J Immunol 166:3923, 2001.
11. Boyington JC, Motyka SA, Scuck P, Brooks AG, Sun PD: Crystal structure of an NK cell immunoglobulin-like receptor in complex with ist class I MHC ligand. Nature 405:537, 2000.
12. Cambell KS, Dessing M, Lopez-Botet M, Cella M, Colanna M: Tyrosine phosphorylation of a human killer inhibitory receptor recruits protein tyrosine phosphatase 1C. J Exp Med 184:93, 1996.
13. Fry AM, Lanier LL, Weiss A: Phosphotyrosines in the killer cell inhibitory receptor motif of NKB1 are required for negative signaling and for association with protein tyrosine phosphatase 1C. J Exp Med 184:295, 1996.
14. Moretta A, Sivori S, Vitali M, Pende D, Morelli L, Augugliaro R, Bottino C, Moretta L: Exixstence of both inhibitory (p58) and activating (p50) receptors for HLA-C molecules in human natural killer cells. J Exp Med 182:875, 1995.
15. Biassoni R, Falco M, Cambiaggi A, Costa P, Verdiani S, Pende D, Conte R, Di Donato C, Parham P, Moretta L: Amino acid substitutions can influence the natural killer (NK) mediated recognition of HLA-C molecules: role of serine-77 and lysine-80 in the target cell protection from lysis mediated by "group 2" or "group 1" NK clones. J Exp Med 182:605, 1995.
16. Valez-Gomez M, Reyburn H, Erskine R, Strominger J: Differential binding to HLA-C of p50-activating and p58-inhibitory natural killer cell receptors. Proc Natl Acad Sci USA 95:14326, 1998.
17. Tonn T, Becker S, Esser R, Schwabe D, Seifried E: Cellular immunotherapy of malignancies using the clonal natural killer cell line NK-92. J Hematother Stem Cell Res 10:535, 2001.
18. Dohring C, Scheidegger D, Samaridis J, Cella M, Colonna M: A human killer inhibitory receptor specific for HLA-A1,2. J Immunol 156:3098, 1996.
19. Litwin V, Gumperz J, Parham P, Phillips JH, Lanier LL: NKBI: a natural killer cell receptor involved in the recognition of polymorphic HLA-B molecules. J Exp Med 180:537, 1994.
20. Pende D, Biassoni R, Cantoni C, Verdinani S, Falco M, Di Donato Caccame L, Bottino C, Moretta A, Moretta L: The natural killer cell receptor specific for HLA-A allotypes: a novel member of the p58/p70 family if inhibitory receptors that is expressed as a 140-kD disulphide-limked dimer. J Exp Med 184:505, 1996.
21. Colonna M, Borsellino G, Falko M, Ferrara GB, Strominger JL: HLA-C is the inhibitory ligand that determines dominnant resistance to lysis by NK1- and NK2-specific natural killer cells. Proc Natl Acad Sci USA 90:12000, 1993.
22. Rajagopalan S, Long EO: A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells. J Exp Med 189:1093, 1999.
23. Ljunggren HG, Karre K: In search of the "missing self:" MHC molecules and NK cell recognition. Immunol Today 11:237, 1990.
24. Valiante NM, Uhrberg M, Shilling HG, Lienert-Weidenbach K, Arnett KL, D'Andrea A, Phillips JH, Lanier LL, Parham P: Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. Immunity 7:739, 1997.
25. Uhrberg M, Viliante NM, Shum BP, Shilling HG, Lienert-Weidenbach K, Corliss B, Tyan D, Lanier LL, Parham P: Human diversity in killer cell inhibitory receptor genes. Immunity 7:753, 1997.
26. Uhrberg M, Parham P, Wernet P: Definition of gene content for nine common group B haplotypes of the Caucasoid population: KIR haplotypes contain between seven and eleven KIR genes. Immunogenetics 54:221, 2002.
27. Baur MP, Danilovs JA: Population analysis of HLA-A, B, C, DR and other genetic markers. In Terasaki PI (ed): Histocompatibility Testing 1980. Los Angeles, CA: UCLA University Press, 1980.
28. Svejgaard A, Platz P, Ryder LP: HLA and disease 1982a survey. Immunol Rev 70:193, 1982.
29. Witt CS, Dewing C, Sayer DC, Uhrberg M, Parham P, Christiansen F: Population frequencies and putative haplotypes of the killer cell immunoglobulin-like receptor sequences and evidence fir recombination. Transplantation 68:1784, 1999.
30. Crum KA, Logue SE, Curran MD, Middleton D: Development of a PCR-SSOP approach capable of defining the natural killer cell inhibitory receptor (KIR) gene sequence repertoires. Tissue Antigens 56:313, 2000.
31. Norman PJ, Stephens HAF, Verity DH, Chandanayingyong D, Vaughan RW: Distribution of natural killer cell immunoglobulin-like receptor sequences in three ethnic groups. Immunogenetics 52:195, 2001.
32. Norman PJ, Carrington CV, Byng M, Maxwell LD, Curran MD, Stephens HA, Chandanayingyong D, Verity DH, Hameed K, Ramdath DD, Vaughan RW: Natural killer cell immunoglobulin-like receptor (KIR) locus profiles in African and South Asian populations. Genes Immunol 3:86, 2002.
33. Toneva M, Lepage V, Lafay G, Dulphy N, Busson M, Lester S, Vu-Trieh A, Michaylova A, Naumova E, Mc-Cluskey J, Charron D: Genomic diversity of natural killer cell receptor genes in three populations. Tissue Antigens 57:358, 2001.
34. Shilling HG, Guethlein LA, Cheng NW, Gardiner CM, Rodriguez R, Tyan D, Parham P: Allelic polymorphism synergizes with variable gene content to individualize human KIR genotype. J Immunol 168:2307, 2002.
35. Ruggeri L, Capanni M, Urbani E, Perruccio K, Shlomchik WD, Tosti A, Posati S, Rogaia D, Frassoni F, Aversa F, Martelli MF, Velardi A: Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 295:2097, 2002.
36. Gagne K, Brizard G, Gueglio B, Milpied N, Herry P, Bonneville F, Cheneau M-L, Schleinitz N, Cesbron A, Follea G, Harrousseau J-L, Bignon J-D: Relevance of KIR gene polymorphisms in bone marrow transplantation outcome. Hum Immunol 63:271, 2002.
37. George T, Yu YY, Liu J, Davenport C, Lemieux S, Stoneman E, Mathew PA, Kumar V, Bennett M: Allorecognition by murine natural killer cells: lysis of T-lymphoblasts and rejection of bone-marrow grafts. Immunol Rev 155:29, 1997.
38. Cambiaggi A, Verthuy C, Naquet P, Romagne F, Ferrier P, Biassoni R, Moretta A, Moretta L, Vivier E: Natural killer cell acceptance of H-2 mismatch bone marrow grafts in transgenic mice expressing HLA-Cw3 specific killer cell inhibitory receptor. Proc Natl Acad Sci USA 94:8088, 1997.
39. Namekawa T, Snyder MR, Jeng-Hsien Y, Goehring BE, Leibson PJ, Weyand CM, Goroanzy JJ: Killer cell activiating receptors function as costimulatory molecules on CD4+CD28null T cells clonally expanded in rheumatoid arthritis. J Immunol 165:1138, 2000.
40. Yen J-H, Moore BE, Nakajima T, Scholl D, Schaid DJ, Weyand CM, Goronzy JJ: Major histocompatibility complex class-I recorgizing receptors are disease risk genes in rheumatoid arthritis. J Exp Med 193:1159, 2001.
41. Gumperz JE, Valiante NM, Parham P, Lanier LL, Tyan D: Heterogeneous phenotypes of expression of the NKB1 natural killer cell class I receptor among individuals of different human histocompatibility leukocyte antigens types appear genetically regulated, but not linked to major histocompatibililty complex haplotyp. J Exp Med 183:1817, 1996.
42. Wagtmann N, Biassoni R, Cantoni C, Verdiani S, Malnati MS, Vitale M, Bottino C, Moretta L, Moretta A, Long EO: Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains. Immunity 2:439, 1995.
43. Gapin L, Matsuda JL, Surh CD, Kronenberg M: NKT cells derive from double-positive thymocytes that are positively selected by CDld. Nat Immunol 2:971, 2001.
44. MacDonald HR: T before NK. Science 246:481, 2002.
45. Young NT, Uhrberg M: KIR expression shapes cytotoxic repertoires: a developmental program of survival. Trends Immunol 23:71, 2002.
46. Miller JS, McCullar V: Human natural killer cells with polyclonal lectin and immunoglobulin-like receptors develop from single hematopoietic stem cells with preferential expression of NKG2A and KIR2DL2/L3/L2. Blood 98:705, 2001.